264 related articles for article (PubMed ID: 21787829)
1. MDCK cell line with inducible allele B NS1 expression propagates delNS1 influenza virus to high titres.
van Wielink R; Harmsen MM; Martens DE; Peeters BP; Wijffels RH; Moormann RJ
Vaccine; 2011 Sep; 29(40):6976-85. PubMed ID: 21787829
[TBL] [Abstract][Full Text] [Related]
2. An A14U Substitution in the 3' Noncoding Region of the M Segment of Viral RNA Supports Replication of Influenza Virus with an NS1 Deletion by Modulating Alternative Splicing of M Segment mRNAs.
Zheng M; Wang P; Song W; Lau SY; Liu S; Huang X; Mok BW; Liu YC; Chen Y; Yuen KY; Chen H
J Virol; 2015 Oct; 89(20):10273-85. PubMed ID: 26223635
[TBL] [Abstract][Full Text] [Related]
3. Influenza A and B viruses expressing altered NS1 proteins: A vaccine approach.
Talon J; Salvatore M; O'Neill RE; Nakaya Y; Zheng H; Muster T; García-Sastre A; Palese P
Proc Natl Acad Sci U S A; 2000 Apr; 97(8):4309-14. PubMed ID: 10725408
[TBL] [Abstract][Full Text] [Related]
4. A genetically engineered influenza A virus with ras-dependent oncolytic properties.
Bergmann M; Romirer I; Sachet M; Fleischhacker R; García-Sastre A; Palese P; Wolff K; Pehamberger H; Jakesz R; Muster T
Cancer Res; 2001 Nov; 61(22):8188-93. PubMed ID: 11719449
[TBL] [Abstract][Full Text] [Related]
5. Generation of DelNS1 Influenza Viruses: a Strategy for Optimizing Live Attenuated Influenza Vaccines.
Wang P; Zheng M; Lau SY; Chen P; Mok BW; Liu S; Liu H; Huang X; Cremin CJ; Song W; Chen Y; Wong YC; Huang H; To KK; Chen Z; Xia N; Yuen KY; Chen H
mBio; 2019 Sep; 10(5):. PubMed ID: 31530680
[TBL] [Abstract][Full Text] [Related]
6. Variation in the ability of human influenza A viruses to induce and inhibit the IFN-beta pathway.
Hayman A; Comely S; Lackenby A; Murphy S; McCauley J; Goodbourn S; Barclay W
Virology; 2006 Mar; 347(1):52-64. PubMed ID: 16378631
[TBL] [Abstract][Full Text] [Related]
7. A new panel of NS1 antibodies for easy detection and titration of influenza A virus.
Tan Z; Akerstrom S; Wee BY; Lal SK; Mirazimi A; Tan YJ
J Med Virol; 2010 Mar; 82(3):467-75. PubMed ID: 20087939
[TBL] [Abstract][Full Text] [Related]
8. Influenza A virus NS1 protein activates the PI3K/Akt pathway to mediate antiapoptotic signaling responses.
Ehrhardt C; Wolff T; Pleschka S; Planz O; Beermann W; Bode JG; Schmolke M; Ludwig S
J Virol; 2007 Apr; 81(7):3058-67. PubMed ID: 17229704
[TBL] [Abstract][Full Text] [Related]
9. A Promising IFN-Deficient System to Manufacture IFN-Sensitive Influenza Vaccine Virus.
Chen C; Fan W; Li J; Zheng W; Zhang S; Yang L; Liu D; Liu W; Sun L
Front Cell Infect Microbiol; 2018; 8():127. PubMed ID: 29765910
[TBL] [Abstract][Full Text] [Related]
10. Development of a live-attenuated influenza B DeltaNS1 intranasal vaccine candidate.
Wressnigg N; Voss D; Wolff T; Romanova J; Ruthsatz T; Mayerhofer I; Reiter M; Nakowitsch S; Humer J; Morokutti A; Muster T; Egorov A; Kittel C
Vaccine; 2009 May; 27(21):2851-7. PubMed ID: 19366569
[TBL] [Abstract][Full Text] [Related]
11. Safety and immunogenicity of a replication-deficient H5N1 influenza virus vaccine lacking NS1.
Nicolodi C; Groiss F; Kiselev O; Wolschek M; Seipelt J; Muster T
Vaccine; 2019 Jun; 37(28):3722-3729. PubMed ID: 31155415
[TBL] [Abstract][Full Text] [Related]
12. Mutations in the M-gene segment can substantially increase replication efficiency of NS1 deletion influenza A virus in MDCK cells.
van Wielink R; Harmsen MM; Martens DE; Peeters BP; Wijffels RH; Moormann RJ
J Virol; 2012 Nov; 86(22):12341-50. PubMed ID: 22951840
[TBL] [Abstract][Full Text] [Related]
13. [Construction and expression of eukaryotic expression vector of NS1 protein of influenza A (H1N1)].
Zhang WS; Bian Q; Wen T; Chi Y; Li Y; Jiao YJ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Mar; 27(3):287-9. PubMed ID: 21419049
[TBL] [Abstract][Full Text] [Related]
14. Mutations in the NS1 protein of swine influenza virus impair anti-interferon activity and confer attenuation in pigs.
Solórzano A; Webby RJ; Lager KM; Janke BH; García-Sastre A; Richt JA
J Virol; 2005 Jun; 79(12):7535-43. PubMed ID: 15919908
[TBL] [Abstract][Full Text] [Related]
15. A Conserved Residue, Tyrosine (Y) 84, in H5N1 Influenza A Virus NS1 Regulates IFN Signaling Responses to Enhance Viral Infection.
Wang BX; Wei L; Kotra LP; Brown EG; Fish EN
Viruses; 2017 May; 9(5):. PubMed ID: 28498306
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity and protection efficacy of replication-deficient influenza A viruses with altered NS1 genes.
Ferko B; Stasakova J; Romanova J; Kittel C; Sereinig S; Katinger H; Egorov A
J Virol; 2004 Dec; 78(23):13037-45. PubMed ID: 15542655
[TBL] [Abstract][Full Text] [Related]
17. Influenza virus subpopulations: exchange of lethal H5N1 virus NS for H1N1 virus NS triggers de novo generation of defective-interfering particles and enhances interferon-inducing particle efficiency.
Ngunjiri JM; Buchek GM; Mohni KN; Sekellick MJ; Marcus PI
J Interferon Cytokine Res; 2013 Mar; 33(3):99-107. PubMed ID: 23215782
[TBL] [Abstract][Full Text] [Related]
18. Effect on virulence and pathogenicity of H5N1 influenza A virus through truncations of NS1 eIF4GI binding domain.
Zhou H; Zhu J; Tu J; Zou W; Hu Y; Yu Z; Yin W; Li Y; Zhang A; Wu Y; Yu Z; Chen H; Jin M
J Infect Dis; 2010 Nov; 202(9):1338-46. PubMed ID: 20854176
[TBL] [Abstract][Full Text] [Related]
19. Phase I/II trial of a replication-deficient trivalent influenza virus vaccine lacking NS1.
Mössler C; Groiss F; Wolzt M; Wolschek M; Seipelt J; Muster T
Vaccine; 2013 Dec; 31(52):6194-200. PubMed ID: 24183981
[TBL] [Abstract][Full Text] [Related]
20. Characterization and evaluation of avian influenza NS1 mutant virus as a potential live and killed DIVA (differentiating between infected and vaccinated animals) vaccine for chickens.
Brahmakshatriya VR; Lupiani B; Reddy SM
Vaccine; 2010 Mar; 28(12):2388-96. PubMed ID: 20064474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
